Instem Revenue and Competitors
Estimated Revenue & Valuation
- Instem's estimated annual revenue is currently $100.5M per year.
- Instem received $2.6M in venture funding in February 2009.
- Instem's estimated revenue per employee is $184,150
Employee Data
- Instem has 546 Employees.
- Instem grew their employee count by 2% last year.
Instem's People
Name | Title | Email/Phone |
---|---|---|
1 | Solution Owner, Aspire | Reveal Email/Phone |
2 | Product Owner | Reveal Email/Phone |
3 | CEO | Reveal Email/Phone |
4 | Corporate VP, Investor Relations | Reveal Email/Phone |
5 | VP, Consulting & Enterprise Hosting | Reveal Email/Phone |
6 | VP Technology and Innovation | Reveal Email/Phone |
7 | SVP, Clinical Trial Acceleration | Reveal Email/Phone |
8 | EVP | Reveal Email/Phone |
9 | V.P. Sales | Reveal Email/Phone |
10 | EVP, Regulatory Solutions | Reveal Email/Phone |
Instem Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $668.1M | 3222 | 3% | $20M | N/A |
#2 | $5.3M | 46 | N/A | N/A | N/A |
#3 | $5.1M | 46 | -13% | $950K | N/A |
#4 | $1.7M | 23 | -4% | $30M | N/A |
#5 | $0.7M | 9 | N/A | N/A | N/A |
#6 | $0.7M | 9 | N/A | N/A | N/A |
#7 | $0.6M | 8 | N/A | N/A | N/A |
#8 | $2.5M | 25 | N/A | N/A | N/A |
#9 | $71M | 300 | -3% | N/A | N/A |
#10 | $14.2M | 98 | N/A | N/A | N/A |
#11 | $5060M | 7612 | -20% | $6.9M | $22.5B |
#12 | $53.7M | 302 | 7% | $8M | N/A |
#13 | $3.8M | 33 | N/A | N/A | N/A |
#14 | $4.2M | 21 | N/A | N/A | N/A |
#15 | $7.6M | 58 | 32% | N/A | N/A |
#16 | $25.7M | 161 | N/A | N/A | N/A |
#17 | $1167M | 5806 | N/A | N/A | N/A |
#18 | $16.5M | 82 | N/A | N/A | N/A |
#19 | $12.7M | 91 | -9% | $17.2M | N/A |
#20 | N/A | 39 | N/A | N/A | N/A |
What Is Instem?
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products. Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information. Instem supports its clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.
keywords:Biotechnology,Healthcare,Information Security,Pharmaceuticals,SecurityN/A
Total Funding
546
Number of Employees
$100.5M
Revenue (est)
2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Instem News
By Jaime Llinares Taboada. Shares in Instem PLC fell Tuesday after the company said that it is lowering its expectations for 2022 due to...
Instem PLC - IT solutions provider based in Staffordshire, England - Posts slightly lower annual revenue than expected for 2021,...
Phil Reason, Instem's chief executive, talks through the latest results for the pharma services group with Proactive.
29 September 2021 Instem plc ("Instem") Appointment of Independent Non-Executive Director Instem plc (AIM: INS), a leading provider of IT solutions to the global life sciences market, announces that it has appointed Riaz Bandali as an independent non-executive director to the Board effective ...
28 September 2021 Instem plc ("Instem", the "Company") Grant of PDMR Options Instem plc (AIM: INS), a leading provider of IT solutions to the global life sciences market, announces that Phil Reason (Chief Executive Officer) and Nigel Goldsmith (Chief Financial Officer) have each been granted ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $159.9M | 624 | -7% | N/A |
#2 | $178.2M | 679 | N/A | N/A |
#3 | $267.6M | 708 | -2% | N/A |
#4 | $1700M | 761 | -2% | N/A |
#5 | $285.6M | 888 | 28% | $40M |
Instem Funding
Date | Amount | Round | Lead Investors | Reference |
---|---|---|---|---|
2009-02-25 | $2.6M | Undisclosed | Article |